{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,20]],"date-time":"2026-02-20T01:14:36Z","timestamp":1771550076677,"version":"3.50.1"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2016,8,30]],"date-time":"2016-08-30T00:00:00Z","timestamp":1472515200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"name":"the Department of Science and Technology Research Projects in the Sichuan Province","award":["2013FZ0015"],"award-info":[{"award-number":["2013FZ0015"]}]},{"DOI":"10.13039\/501100001809","name":"the National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["81271321"],"award-info":[{"award-number":["81271321"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Neurobiol"],"published-print":{"date-parts":[[2017,9]]},"DOI":"10.1007\/s12035-016-0070-5","type":"journal-article","created":{"date-parts":[[2016,8,30]],"date-time":"2016-08-30T10:31:47Z","timestamp":1472553107000},"page":"5236-5242","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Association of CD40 Gene Polymorphisms with Susceptibility to Neuromyelitis Optica Spectrum Disorders"],"prefix":"10.1007","volume":"54","author":[{"given":"Ziyan","family":"Shi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hongxi","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaohui","family":"Miao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ju","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhiyun","family":"Lian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Huiru","family":"Feng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hongyu","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2016,8,30]]},"reference":[{"issue":"10","key":"70_CR1","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1212\/01.wnl.0000216139.44259.74","volume":"66","author":"DM Wingerchuk","year":"2006","unstructured":"Wingerchuk DM, Lennon VA, Pittock SJ, Lucchinetti CF, Weinshenker BG (2006) Revised diagnostic criteria for neuromyelitis optica. Neurology 66(10):1485\u20131489","journal-title":"Neurology"},{"issue":"9","key":"70_CR2","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1016\/S1474-4422(07)70216-8","volume":"6","author":"DM Wingerchuk","year":"2007","unstructured":"Wingerchuk DM, Lennon VA, Lucchinetti CF, Pittock SJ, Weinshenker BG (2007) The spectrum of neuromyelitis optica. Lancet Neurol 6(9):805\u2013815","journal-title":"Lancet Neurol"},{"issue":"9451","key":"70_CR3","doi-asserted-by":"crossref","first-page":"2106","DOI":"10.1016\/S0140-6736(04)17551-X","volume":"364","author":"VA Lennon","year":"2004","unstructured":"Lennon VA, Wingerchuk DM, Kryzer TJ, Pittock SJ, Lucchinetti CF, Fujihara K, Nakashima I, Weinshenker BG (2004) A serum autoantibody marker of neuromyelitis optica: distinction from multiple sclerosis. Lancet 364(9451):2106\u20132112","journal-title":"Lancet"},{"issue":"2","key":"70_CR4","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1212\/WNL.0000000000001729","volume":"85","author":"DM Wingerchuk","year":"2015","unstructured":"Wingerchuk DM, Banwell B, Bennett JL, Cabre P, Carroll W, Chitnis T, de Seze J, Fujihara K, et al. (2015) International consensus diagnostic criteria for neuromyelitis optica spectrum disorders. Neurology 85(2):177\u2013189","journal-title":"Neurology"},{"issue":"9","key":"70_CR5","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1016\/j.biocel.2012.06.013","volume":"44","author":"J Ratelade","year":"2012","unstructured":"Ratelade J, Verkman AS (2012) Neuromyelitis optica: aquaporin-4 based pathogenesis mechanisms and new therapies. Int J Biochem Cell Biol 44(9):1519\u20131530","journal-title":"Int J Biochem Cell Biol"},{"issue":"5","key":"70_CR6","first-page":"307","volume":"66","author":"SJ Pittock","year":"2006","unstructured":"Pittock SJ, Lennon VA, Wingerchuk DM (2006) The prevalence of non-organ-specific autoantibodies and NMO-IgG in neuromyelitis optica (NMO) and related disorders. Neurology 66(5):307","journal-title":"Neurology"},{"issue":"1","key":"70_CR7","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1186\/1471-2377-14-57","volume":"14","author":"JY Kim","year":"2014","unstructured":"Kim JY, Bae JS, Kim HJ, et al. (2014) CD58 polymorphisms associated with the risk of neuromyelitis optica in a Korean population. BMC Neurol 14(1):57","journal-title":"BMC Neurol"},{"issue":"1","key":"70_CR8","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1007\/s12035-014-9036-7","volume":"53","author":"X Wang","year":"2016","unstructured":"Wang X, Yu T, Yan Q, Wang W2, Meng N, Li X, Luo Y (2016) Significant association between Fc receptor-like 3 polymorphisms (-1901A>G and -658C>T) and neuromyelitis optica (NMO) susceptibility in the Chinese population. Mol Neurobiol 53(1):686\u2013694","journal-title":"Mol Neurobiol"},{"issue":"1","key":"70_CR9","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1007\/BF00199769","volume":"20","author":"S Paulie","year":"1985","unstructured":"Paulie S, Ehlin-Henriksson B, Mellstedt H, Koho H, Ben-Aissa H, Perlmann P (1985) A p50 surface antigen restricted to human urinary bladder carcinomas and B lymphocytes. Cancer Immunol Immunother 20(1):23\u201328","journal-title":"Cancer Immunol Immunother"},{"issue":"5","key":"70_CR10","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.smim.2009.08.002","volume":"21","author":"GA Bishop","year":"2009","unstructured":"Bishop GA (2009) The many faces of CD40: multiple roles in normal immunity and disease. Semin Immunol 2009 21(5):255\u2013256","journal-title":"Semin Immunol 2009"},{"issue":"1","key":"70_CR11","first-page":"1","volume":"16","author":"JM Chen","year":"2015","unstructured":"Chen JM, Guo J, Wei CD, Wang CF, Luo HC, Wei YS, Lan Y (2015) The association of CD40 polymorphisms with CD40 serum levels and risk of systemic lupus erythematosus. BMC Genet 16(1):1","journal-title":"BMC Genet"},{"issue":"4","key":"70_CR12","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1093\/rheumatology\/kes339","volume":"52","author":"YB Joo","year":"2013","unstructured":"Joo YB, Park BL, Shin HD, Park SY, Kim I, Bae SC (2013) Association of genetic polymorphisms in CD40 with susceptibility to SLE in the Korean population. Rheumatology 52(4):623\u2013630","journal-title":"Rheumatology"},{"issue":"8","key":"70_CR13","doi-asserted-by":"crossref","first-page":"2242","DOI":"10.1002\/art.24721","volume":"60","author":"MPM Van der Linden","year":"2009","unstructured":"Van der Linden MPM, Feitsma AL, le Cessie S, Kern M, Olsson LM, Raychaudhuri S, Begovich AB, Chang M, et al. (2009) Association of a single-nucleotide polymorphism in CD40 with the rate of joint destruction in rheumatoid arthritis. Arthritis Rheum 60(8):2242\u20132247","journal-title":"Arthritis Rheum"},{"key":"70_CR14","doi-asserted-by":"crossref","first-page":"13995","DOI":"10.1038\/srep13995","volume":"5","author":"C Casiraghi","year":"2015","unstructured":"Casiraghi C, M\u00e1rquez AC, Shanina I, Horowitz MS (2015) Latent virus infection upregulates CD40 expression facilitating enhanced autoimmunity in a model of multiple sclerosis. Sci Rep 5:13995","journal-title":"Sci Rep"},{"issue":"7","key":"70_CR15","doi-asserted-by":"crossref","first-page":"e11520","DOI":"10.1371\/journal.pone.0011520","volume":"5","author":"F Blanco-Kelly","year":"2010","unstructured":"Blanco-Kelly F, Matesanz F, Alcina A, Teruel M, D\u00edaz-Gallo LM, G\u00f3mez-Garc\u00eda M, L\u00f3pez-Nevot MA, Rodrigo L, et al. (2010) CD40: novel association with Crohn\u2019s disease and replication in multiple sclerosis susceptibility. PLoS One 5(7):e11520","journal-title":"PLoS One"},{"issue":"10","key":"70_CR16","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1089\/105072503322511319","volume":"13","author":"TY Kim","year":"2003","unstructured":"Kim TY, Park YJ, Hwang JK, Song JY, Park KS, Cho BY, Park DJ (2003) A C\/T polymorphism in the 5\u2032-untranslated region of the CD40 gene is associated with Graves\u2019 disease in Koreans. Thyroid 13(10):919\u2013925","journal-title":"Thyroid"},{"key":"70_CR17","doi-asserted-by":"crossref","unstructured":"Bahlo M, Booth DR, Broadley SA, et al., Australia and New Zealand Multiple Sclerosis Genetics Consortium (ANZgene) (2009) Genome-wide association study identifies new multiple sclerosis susceptibility loci on chromosomes 12 and 20. Nat Genet 41(7):824-828.","DOI":"10.1038\/ng.396"},{"issue":"11","key":"70_CR18","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1212\/WNL.33.11.1444","volume":"33","author":"JF Kurtzke","year":"1983","unstructured":"Kurtzke JF (1983) Rating neurologic impairment in multiple sclerosis an expanded disability status scale (EDSS). Neurology 33(11):1444\u20131452","journal-title":"Neurology"},{"issue":"2","key":"70_CR19","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1038\/sj.cr.7290272","volume":"15","author":"YY Shi","year":"2005","unstructured":"Shi YY, He L (2005) SHEsis, a powerful software platform for analyses of linkage disequilibrium, haplotype construction, and genetic association at polymorphism loci. Cell Res 15(2):97\u201398","journal-title":"Cell Res"},{"issue":"10","key":"70_CR20","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/0167-5699(96)10060-I","volume":"17","author":"RD Stout","year":"1996","unstructured":"Stout RD, Suttles J (1996) The many roles of CD40 in cell-mediated inflammatory responses. Immunol Today 17(10):487\u2013492","journal-title":"Immunol Today"},{"issue":"3","key":"70_CR21","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/S1359-6101(03)00024-8","volume":"14","author":"GA Bishop","year":"2003","unstructured":"Bishop GA, Hostager BS (2003) The CD40-CD154 interaction in B cell-T cell liaisons. Cytokine Growth Factor Rev 14(3):297\u2013309","journal-title":"Cytokine Growth Factor Rev"},{"issue":"3","key":"70_CR22","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1073\/pnas.0810769106","volume":"106","author":"G Iezzi","year":"2009","unstructured":"Iezzi G, Sonderegger I, Ampenberger F, Schmitz N, Marsland BJ, Kopf M (2009) CD40\u2013CD40L cross-talk integrates strong antigenic signals and microbial stimuli to induce development of IL-17-producing CD4+ T cells. Proceedings of the National Academy of Sciences 106(3):876\u2013881","journal-title":"Proceedings of the National Academy of Sciences"},{"issue":"3","key":"70_CR23","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1038\/nrg.2015.33","volume":"17","author":"M Gutierrez-Arcelus","year":"2016","unstructured":"Gutierrez-Arcelus M, Rich SS, Raychaudhuri S (2016) Autoimmune diseases\u2014connecting risk alleles with molecular traits of the immune system [J]. Nat Rev Genet 17(3):160\u2013174","journal-title":"Nat Rev Genet"},{"issue":"1","key":"70_CR24","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1002\/ana.23651","volume":"72","author":"M Varrin-Doyer","year":"2012","unstructured":"Varrin-Doyer M, Spencer CM, Schulze-Topphoff U, Nelson PA, Stroud RM, Cree BA, Zamvil SS (2012) Aquaporin 4-specific T cells in neuromyelitis optica exhibit a Th17 bias and recognize clostridium ABC transporter. Ann Neurol 72(1):53\u201364","journal-title":"Ann Neurol"},{"issue":"6","key":"70_CR25","doi-asserted-by":"crossref","first-page":"2499","DOI":"10.1073\/pnas.93.6.2499","volume":"93","author":"K Gerritse","year":"1996","unstructured":"Gerritse K, Laman JD, Noelle RJ, Aruffo A, Ledbetter JA, Boersma WJ, Claassen E (1996) CD40-CD40 ligand interactions in experimental allergic encephalomyelitis and multiple sclerosis [J]. Proc Natl Acad Sci U S A 93(6):2499\u20132504","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"6689","key":"70_CR26","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1038\/28204","volume":"394","author":"F Mach","year":"1998","unstructured":"Mach F, Sch\u00f6nbeck U, Sukhova GK, Atkinson E, Libby P (1998) Reduction of atherosclerosis in mice by inhibition of CD40 signalling. Nature 394(6689):200\u2013203","journal-title":"Nature"},{"key":"70_CR27","doi-asserted-by":"crossref","first-page":"1328","DOI":"10.1126\/science.7689748","volume":"261","author":"FH Durie","year":"1993","unstructured":"Durie FH, Fava RA, Foy TM, Aruffo A, Ledbetter JA, Noelle RJ (1993) Prevention of collagen-induced arthritis with an antibody to gp39, the ligand for CD40. Science 261:1328\u20131328","journal-title":"Science"},{"key":"70_CR28","doi-asserted-by":"crossref","first-page":"1470","DOI":"10.4049\/jimmunol.154.3.1470","volume":"154","author":"C Mohan","year":"1995","unstructured":"Mohan C, Shi Y, Laman JD, Datta SK (1995) Interaction between CD40 and its ligand gp39 in the development of murine lupus nephritis. J Immunol 154:1470\u20131480","journal-title":"J Immunol"},{"key":"70_CR29","first-page":"421","volume":"90","author":"G Carayanniotis","year":"1997","unstructured":"Carayanniotis G, Master SR, Noelle RJ (1997) Suppression of murine thyroiditis via blockade of the CD40-CD40L interaction. Immunity 90:421\u2013426","journal-title":"Immunity"},{"issue":"5","key":"70_CR30","doi-asserted-by":"crossref","first-page":"939","DOI":"10.3899\/jrheum.111336","volume":"39","author":"L \u00c4rlestig","year":"2012","unstructured":"\u00c4rlestig L, Rantap\u00e4\u00e4-Dahlqvist S (2012) Polymorphisms of the genes encoding CD40 and growth differentiation factor 15 and in the 9p21.3 region in patients with rheumatoid arthritis and cardiovascular disease. J Rheumatol 39(5):939\u2013945","journal-title":"J Rheumatol"},{"issue":"10","key":"70_CR31","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1038\/ng.233","volume":"40","author":"S Raychaudhuri","year":"2008","unstructured":"Raychaudhuri S, Remmers EF, Lee AT, et al. (2008) Common variants at CD40 and other loci confer risk of rheumatoid arthritis [J]. Nat Genet 40(10):1216\u20131223","journal-title":"Nat Genet"},{"issue":"5","key":"70_CR32","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1136\/ard.2009.109579","volume":"69","author":"G Orozco","year":"2010","unstructured":"Orozco G, Eyre S, Hinks A, et al. (2010) Association of CD40 with rheumatoid arthritis confirmed in a large UK case-control study [J]. Ann Rheum Dis 69(5):813\u2013816","journal-title":"Ann Rheum Dis"},{"key":"70_CR33","doi-asserted-by":"crossref","unstructured":"Vazgiourakis V M, Zervou M I, Choulaki C, et al.(2011) A common SNP in the CD40 region is associated with systemic lupus erythematosus and correlates with altered CD40 expression: implications for the pathogenesis [J]. Annals of the Rheumatic Diseases, annrheumdis146530.","DOI":"10.1136\/ard.2010.146530"},{"issue":"2","key":"70_CR34","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1002\/art.24245","volume":"60","author":"HS Lee","year":"2009","unstructured":"Lee HS, Korman BD, Le JM, et al. (2009) Genetic risk factors for rheumatoid arthritis differ in Caucasian and Korean populations [J]. Arthritis & Rheumatism 60(2):364\u2013371","journal-title":"Arthritis & Rheumatism"},{"issue":"6","key":"70_CR35","doi-asserted-by":"crossref","first-page":"2684","DOI":"10.1210\/en.2004-1617","volume":"146","author":"EM Jacobson","year":"2005","unstructured":"Jacobson EM, Concepcion E, Oashi T, Tomer Y (2005) A Graves\u2019 disease-associated Kozak sequence single-nucleotide polymorphism enhances the efficiency of CD40 gene translation: a case for translational pathophysiology. Endocrinology 146(6):2684\u20132691","journal-title":"Endocrinology"},{"issue":"4","key":"70_CR36","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1159\/000342621","volume":"1","author":"PW Wang","year":"2012","unstructured":"Wang PW, Chen IY, Juo SH, Hsi E, Liu RT, Hsieh CJ (2012) Genotype and phenotype predictors of relapse of Graves\u2019 disease after antithyroid drug withdrawal. Eur Thyroid J 1(4):251\u2013258","journal-title":"Eur Thyroid J"},{"key":"70_CR37","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.jaut.2015.07.009","volume":"64","author":"HJ Lee","year":"2015","unstructured":"Lee HJ, Li CW, Hammerstad SS, Stefan M, Tomer Y (2015) Immunogenetics of autoimmune thyroid diseases: a comprehensive review. J Autoimmun 64:82\u201390","journal-title":"J Autoimmun"},{"key":"70_CR38","doi-asserted-by":"crossref","unstructured":"Gandhi K S, McKay F C, Cox M, et al. (2010) The multiple sclerosis whole blood mRNA transcriptome and genetic associations indicate dysregulation of specific T cell pathways in pathogenesis [J]. Human molecular genetics, ddq090.","DOI":"10.1093\/hmg\/ddq090"}],"container-title":["Molecular Neurobiology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12035-016-0070-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-016-0070-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-016-0070-5","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-016-0070-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,19]],"date-time":"2023-08-19T22:10:28Z","timestamp":1692483028000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12035-016-0070-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,8,30]]},"references-count":38,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2017,9]]}},"alternative-id":["70"],"URL":"https:\/\/doi.org\/10.1007\/s12035-016-0070-5","relation":{},"ISSN":["0893-7648","1559-1182"],"issn-type":[{"value":"0893-7648","type":"print"},{"value":"1559-1182","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,8,30]]}}}